Key statistics
On Thursday, Vera Therapeutics Inc (VERA:NMQ) closed at 47.03, -8.87% below its 52-week high of 51.61, set on Nov 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 47.16 |
---|---|
High | 48.28 |
Low | 46.16 |
Bid | -- |
Offer | -- |
Previous close | 45.75 |
Average volume | 666.97k |
---|---|
Shares outstanding | 63.32m |
Free float | 59.05m |
P/E (TTM) | -- |
Market cap | 2.98bn USD |
EPS (TTM) | -2.60 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
- Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study
- Vera Therapeutics to Participate at Upcoming Investor Conferences
- Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
- Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
- Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
- Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
- Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases
- Vera Therapeutics Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024
More ▼